Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testicular Cancer Treatment: Assessing Quality of Life in Good Prognosis Metastastic Disease

NCT07498959 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT07498959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07498959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testicular Cancer Treatment: Assessing Quality of Life in Good Prognosis Metastastic Disease
Lead sponsor
Sahlgrenska University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 19, 2026
Completion date
March 25, 2032
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de-escalation, quality of life, rplnd, seminoma, testicular cancer